The navenibart phase 3 program will consist of the ALPHA-ORBIT phase 3 trial and the long-term extension trial, which are designed to support registration globally. Global start-up activities ...

(NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced its planned design of the ALPHA-ORBIT Phase 3 ...

Alpha's current MD, Rimas Kairaitis, has been moved to the role of chief commercial officer. The context: Alpha said the leadership changes "reflect the needs of the business into the future as the ...

Considering the double-well potential can help simulate only two phases, ferrite and cementite, which is less compatible with the experiment results than the triple-well potential, which gives the ...

This drug basically combines low-dose IL-2 and CTLA4-Ig, and it’s now progressing toward Phase 2 trials for ALS ... for it (other than from Seeking Alpha). I have no business relationship ...

Strong Financial Position, Funded Through Expected Top-Line Phase 3 Results -- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing ...

Alpha measures a manager's skill in adding value to a portfolio beyond market gains. Beta assesses how a stock or fund's volatility compares to the market average. High alpha and low beta indicate ...

After hours: February 7 at 7:57:14 PM EST Loading Chart for AOSL ...

Cricut experienced a meteoric boom during the pandemic, but its "coming back to earth" has spooked investors. A close look at operational and financial metrics suggests significant potential value ...

What is the moon phase today? Today, Feb. 9, 2025, the moon is 11 days old, in the Waxing Gibbous phase of its lunar cycle. It is 91% illuminated. Moon phases reveal the passage of time in the ...

Marvel Phase 6 hasn't yet kicked off, with the MCU still deep in Phase 5. The current era is all about the multiverse, thanks to the likes of Loki, Doctor Strange and The Marvels, while the ...